Testing effectiveness (Phase 2)Study completedNCT00000771
What this trial is testing
A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 68